SCHEMBL7357397

SCHEMBL7357397

N#Cc1ccc2c(c1)[nH]c(=O)c(=O)n2CP(=O)(O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 6/20 0.59
GRIN1 Q05586 4/20 0.59
GRIA1 P42261 4/20 0.59
GRIA3 P42263 4/20 0.59
GRIA4 P48058 4/20 0.59
GRIN2D O15399 3/20 0.59
GRIN3B O60391 3/20 0.59
GRIN2A Q12879 3/20 0.59
GRIN2B Q13224 3/20 0.59
GRIN2C Q14957 3/20 0.59
GRIN3A Q8TCU5 3/20 0.59
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
GRIK3 Q13003 3/20 0.39
GRIK2 Q13002 2/20 0.39
GRIK1 P39086 2/20 0.39
GRIK5 Q16478 1/20 0.39
FASN P49327 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955880 0.83 GRIA1 (0.71) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7349363 0.80 GRIA1 (0.63) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7350271 0.80 GRIA1 (0.63) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7356582 0.80 GRIN2D (0.63) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7355341 0.80 GRIN2D (0.63) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7356050 0.80 GRIA1 (0.63) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7360391 0.77 GRIA1 (0.59) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL9364749 0.76 DAO (0.44) GRIA2GRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL7350733 0.76 GRIN2D (0.57) GRIA2GRIN1GRIA1GRIA3GRIA4
SCHEMBL7352049 0.76 GRIA1 (0.51) GRIA2GRIN1GRIA1GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288065-B1 CENTRAL NERVOUS SYSTEM DISORDERS; PARKINSON*S AND ALZHEIMER*S DISEASE SCHERING AKTIENGESEELLSCHAFT (DE) 2001-09-11 US disclosed
US-6057304-A Quinoxaline-phosphonic acid derivatives SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed
WO-1993008173-A1 QUINOXALINE DERIVATES WITH AFFINITY FOR QUISQUALATE-RECEPTORS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-29 WO disclosed